Cultures of Langerhans cells and co-culture with lymphoid cells: Relevance to toxicology and pharmacology.
Langerhans cells are an essential component of cutaneous immunological defence mechanisms. They are mononuclear dendritic cells derived from bone marrow, which are present in the squamous epithelia, particularly skin. Langerhans cells show marked changes in phenotype and function when epidermal cell suspensions are prepared according to a trypsinization protocol and placed in culture for 1-3 days. They seem to mature and acquire most of the features of lymphoid dendritic cells, especially the interdigitating dendritic cells present in lymph nodes. This observation supports the assertion that resident Langerhans cells take up foreign antigens and then migrate through dermal lymphatics to local lymph nodes where they function as antigen-presenting cells. Thus, Langerhans cells play a pivotal role in the primary immune response and in the pathogenesis of skin diseases. In the past, most therapeutic treatment of skin diseases was achieved by administration of pharmacological agents by epicutaneous application. More recently, the determination of the toxicity of drugs and their pharmacological mechanisms has required the development of in vitro models to explore their potential effects at the cellular level. The effects of different agents (physical and chemical) on the density and function of fresh or cultured Langerhans cells are reviewed.
Dezutter-Dambuyant
C
C
Laboratoire de Recherche Dermatologique et Immunologie, Unité INSERM 209, Hôpital Edouard Herriot, 69374 Lyon, Cedex 2, France.